Navigation Links
Alliqua Initiates Life-Cycle Management Plan to Expand Wound Care Portfolio for Use in Broader Wound Indications
Date:3/22/2013

NEW YORK, March 22, 2013 /PRNewswire/ -- Alliqua, Inc. (OTCQB:ALQA) ("Alliqua" or the "Company") today announced the initiation of a life-cycle management plan as the first phase in their portfolio expansion initiative. As part of this plan, Alliqua is making a number of product changes designed to increase adoption of SilverSeal® and Hydress® dressings. Alliqua intends that these ongoing planned modifications will address the needs of patients with a broader range of wounds as well as the specific needs of their various clinical customers. Customers should expect to see the first of these updated dressings in May 2013.

"We believe that these changes and the expansion of our dressing portfolio will increase the overall number of patients who can benefit from our technology. Feedback from our customers and a market survey we conducted suggests these changes are important considerations for physicians and patients when selecting a hydrogel dressing," said David Johnson, Alliqua's chief executive officer. "Our life-cycle management initiatives are designed to ensure our SilverSeal® and Hydress® products provide compelling solutions for our customers."

The Company expects to file a 510(k) application with the FDA for clearance of SilverSeal® incorporating additional modifications by mid 2013, after which a decision from the FDA may be forthcoming as early as the end of the year.

About Alliqua, Inc.  
Alliqua, Inc. (ALQA) ("Alliqua") is a biopharmaceutical company focused on the development, manufacturing, and distribution of proprietary transdermal wound care and drug delivery technologies. Alliqua's leading technology pla
'/>"/>

SOURCE Alliqua, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Alliqua Strengthens and Realigns Executive Team
2. Alliqua Names David Johnson Executive Chairman of Aquamed Technologies and Member of Alliqua Board of Directors
3. Alliqua to Explore Business Development Efforts for Hydrogel Transdermal Delivery Platform in the Cosmeceutical Industry
4. Alliqua Appoints Dr. Joseph Laudano as Vice President of Medical Affairs to Support the Market Expansion of Alliquas SilverSeal Products and Future Clinical Development
5. Lithera Initiates Phase 2b Clinical Trial of LIPO-202 Targeting Aesthetic Reduction of Subcutaneous Abdominal Fat
6. Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-CRP Rx In Patients With Atrial Fibrillation
7. NxStage Initiates 2013 Call to Action Campaign with Launch of Hemodialysis At Home: A Better Way For a Better Life
8. Coyote Pharmaceuticals Initiates GMP Manufacturing Process for CNS-102 Following Successful Pre-IND Meeting
9. Nanomix Initiates Clinical Testing of Point of Care IVD Cardiac Panel
10. ADVENTRX Initiates Pivotal Phase 3 Study of ANX-188
11. uniQure Initiates Phase I in Acute Intermittent Porphyria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... , June 30, 2015  IGI Laboratories, Inc. ... based specialty generic pharmaceutical company, today announced it ... to the U.S. Food and Drug Administration (FDA) of ... submissions now pending at the FDA to twenty-seven. ... the Company, commented, "We believe our current pipeline of ...
(Date:6/30/2015)... Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX ... the development and commercialization of Locilex® (pexiganan cream ... announced underwritten public offering of 1,480,000 shares of ... option in full to purchase an additional 222,000 ... proceeds to Dipexium are expected to be approximately ...
(Date:6/30/2015)... 2015  Today, the National Mobility Equipment Dealers Association ... Mobility Awareness Month Local Heroes Contest on National TV. ... that received 1.3 million votes. The sponsors for the ... Mobility , and Valley Honda Dealers , with ... Vantage Mobility International (VMI) and ElDorado Mobility ...
Breaking Medicine Technology:IGI Laboratories, Inc. Announces Fifth ANDA Submission Of 2015 2Dipexium Announces Closing of Public Offering of Common Stock 2Dipexium Announces Closing of Public Offering of Common Stock 3NMEDA Announces National Contest Winners 2NMEDA Announces National Contest Winners 3
... Aug. 2 Novalar Pharmaceuticals, Inc., a specialty pharmaceutical company focused ... again been selected by leading dental industry magazine Dentistry Today as one ... 24th annual competition were published in the July issue.   , ... OraVerse is the first ...
... , ST. LOUIS ,  Aug. 2 K-V Pharmaceutical ... received notification from the New York Stock Exchange ("NYSE") on ... quantitative continued listing standards.  The NYSE informed the Company that ... criteria for the average closing price of a NYSE security ...
Cached Medicine Technology:OraVerse® Named as One of Dentistry Today's 'Top 100 Products' for Second Year 2OraVerse® Named as One of Dentistry Today's 'Top 100 Products' for Second Year 3K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 2K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 3K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 4K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 5K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 6K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 7K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 8K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 9
(Date:6/30/2015)... , ... June 30, 2015 , ... ... UHMS approved 40-hour Introduction to Hyperbaric Medicine Course. Clinicians from WCA partnering hospitals ... hyperbaric medicine curriculum. , Wound care and hyperbaric medicine education and training ...
(Date:6/30/2015)... IL (PRWEB) , ... June 30, 2015 , ... The ... educate women on fertility preservation and deciding the right age to pursue egg freezing. ... until after the age of 35 — a 150 percent increase since the 1970s. ...
(Date:6/30/2015)... Sacramento, CA (PRWEB) , ... June 30, 2015 ... ... on YouTube titled, “University Post-Acute Rehab”. The video focuses on the rehab center’s ... Five-Star rating, indicating it provides the best quality of services available. Each patient ...
(Date:6/30/2015)... ... June 30, 2015 , ... Lakeview Health, a ... doubled the size of its medical staff to further enhance its ability to ... physicians, nurse practitioners and physician assistants -- now totals 17, compared to 7 ...
(Date:6/30/2015)... ... 2015 , ... Rocky Mountain Oils, a leading non-MLM supplier of premium ... new CEO, Mr. Darold Francis. The changes will help enhance the company’s focus on ... have come to know and respect for over eight years. , “I am thrilled ...
Breaking Medicine News(10 mins):Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 2Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 3Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 4Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 5Health News:Patients of University Post-Acute Rehab Support Five-Star Rating in New Video 2Health News:Lakeview Health, a Nationally Recognized Drug Rehabilitation Center in Florida, Doubles Size of Medical Staff 2Health News:Rocky Mountain Oils Adds New CEO, Announces Relocation of Operations to Orem, Utah 2
... containing benadryl linked to slowed thinking, delirium in ... News) --Older people taking common over-the-counter drugs for ... increase their risk for cognitive impairment, including delirium, ... include Benadryl, Dramamine, Excedrin PM, Nytol, Sominex, Tylenol ...
... healthcare IT company by revenue , , HATBORO, Pa., June ... IFLG ), a leading technology provider of enterprise mobility solutions for ... been named to Healthcare Informatics , ... , , (Logo: http://www.newscom.com/cgi-bin/prnh/20071101/NETH165LOGO ...
... Programs Give Seniors Helpful Solutions , , HOUSTON, ... nation,s largest non-profit organization for seniors, with over 500,000 ... Support & Financial and Retirement Planning. , , ... of resources to SCB members, with the goal of ...
... ... based clinic - The London Clinic. The contract marks the world,s first live site of ... ... leading provider of clinical workflow and integration technology for the health care sector world-wide, has ...
... Best ... minded individual. , ... London, England (PRWEB) June 5, 2009 -- Best Pills Inc is proud to announce ... ,The site is unique in its offering of popularly prescribed "discreet" prescription drugs ...
... PROVO, Utah, June 4 Nu Skin Enterprises, Inc. (NYSE: ... has declared a quarterly dividend of $0.115 per share, which ... record on June 15, 2009. , , The ... has been demonstrating its tradition of innovation through its comprehensive ...
Cached Medicine News:Health News:Some OTC Sleep, Cold Meds Could Harm Aging Brain 2Health News:Some OTC Sleep, Cold Meds Could Harm Aging Brain 3Health News:InfoLogix Named as One of the Top 50 Healthcare Information Technology Companies in the World 2Health News:InfoLogix Named as One of the Top 50 Healthcare Information Technology Companies in the World 3Health News:Senior Citizens Bureau Creates New Resourceful Divisions 2Health News:Orion Health Live at Harley Street Clinic 2Health News:Orion Health Live at Harley Street Clinic 3Health News:Bestpills Launchs its New Online Pharmacy 2
... The MicroAire® Hi Speed Pulse Lavage ... bone surfaces as well as cleansing ... Now a great system just got ... effective with the addition of ...
... Staple is a novel shape memory alloy bone ... of its Nitinol construction, the prongs of the ... upon application of a heating current. This results ... response of bone and cause adjustable compression across ...
... deformity of the ankle joint with ... fusion of the ankle joint, fractures ... where reconstruction is impossible, and fracture/dislocations ... severe arthritic changes and loss of ...
The Buechel-pappas™ Total Ankle Replacement is a time-tested system which is the result of more than twenty years of development, clinical investigation, and use. The components have been avai...
Medicine Products: